GHB / GBL:
The Narrowest Window of Any Rave Drug
Evidence-based harm reduction for GHB and GBL. Street names: G, Liquid G, Gina, Liquid Ecstasy, Georgia Home Boy, Grievous Bodily Harm, Easy Lay, Fantasy, Blue Nitro, Gamma-OH. GBL also sold as: Lactone, Chem.
This is not medical advice. GHB and GBL are controlled substances in most jurisdictions and carry serious risks including overdose death. This information is for people who have already decided to use and want to minimize harm. If someone has overdosed or lost consciousness, call emergency services immediately.
The Critical Risks
Narrowest Therapeutic Window
The difference between a recreational GHB dose and one that causes unconsciousness can be less than 1ml of liquid. This is the narrowest margin of any commonly used party substance. Concentration varies between sources — the same volume can be dramatically different in effect.
Alcohol Combination Kills
Most GHB-related deaths involve concurrent alcohol use. GHB and alcohol are both GABA-receptor CNS depressants — combined, their effects are synergistic (multiplicative), not simply additive. Even a single drink substantially lowers the dose at which respiratory failure occurs.
No Antidote
Unlike opioid overdose (which can be reversed with naloxone), there is no pharmacological reversal agent for GHB overdose. Treatment is entirely supportive. Calling emergency services and placing the person in the recovery position are the only available responses.
GBL Is 2–3× Stronger
GBL (sold as Lactone or Chem) is converted to GHB in your body within minutes. It is approximately 2–3× more potent than GHB by volume and has a faster, sharper onset. Dosing GBL the same as GHB will likely cause overdose. These are not interchangeable.
GHB vs. GBL — Not the Same Drug
GBL (gamma-butyrolactone) is a precursor chemical that your body converts to GHB (gamma-hydroxybutyrate) rapidly after ingestion. They share the same mechanism but differ significantly in potency, onset speed, and legal status. This distinction matters for dosing.
GHB (Gamma-Hydroxybutyrate)
The Active Compound- Mechanism: GABA-B receptor agonist; also acts at GHB-specific receptors
- Onset: 20–60 minutes (oral)
- Duration: 1.5–3 hours
- Form: Clear, slightly salty liquid; sometimes powder
- Legal status: Schedule I in the US (Schedule III as pharmaceutical Xyrem for narcolepsy); Class C in UK
- Sold as: G, Liquid G, Gina, Georgia Home Boy, Liquid Ecstasy, Grievous Bodily Harm, Fantasy, Blue Nitro, Gamma-OH
GBL (Gamma-Butyrolactone)
2–3× More Potent by Volume- Mechanism: Prodrug — converted to GHB in the body within minutes by lactonase enzymes
- Onset: 15–30 minutes — faster and more abrupt than GHB
- Potency: Approximately 2–3× that of GHB by volume
- Form: Clear, oily liquid with a slightly different smell; also sold as industrial solvent
- Legal status: Legal industrial chemical in many jurisdictions (sold as wheel cleaner, paint stripper, Lactone, Chem) — but controlled in some countries
- Sold as: Lactone, Chem, GBL Cleaner — and sometimes mislabeled as GHB
Never assume GBL is GHB. If you normally dose 1.5ml of GHB, the equivalent GBL dose would be approximately 0.5–0.75ml. Starting with your GHB dose of GBL risks serious overdose.
Dose by Milliliters. Always.
GHB and GBL are almost always sold as liquids of unknown concentration. "A gram" or "a spoon" are meaningless — what matters is the concentration of the batch. Different sources will have radically different potencies. A precise measuring syringe (1ml, graduated) is the only safe measurement tool. Get 1ml oral syringes →
GHB Dose Ranges (Rough Guidelines Only)
Concentration Varies — Start LowThese assume zero alcohol. Even 1–2 standard drinks can shift the overdose threshold dramatically downward. Individual tolerance varies. If you don't know the concentration of a batch, start at 0.5ml and wait the full onset time before considering more.
Timeline
Wait for Full Onset Before RedosingGBL onset is faster: 15–30 minutes. Do not redose GBL before 1.5–2 hours and only if effects are fully resolved. Premature redosing combined with delayed onset of the first dose is a frequent cause of accidental overdose.
Safe Dosing Practices
Every Time- Use a 1ml graduated syringe — measure liquid precisely, not by cap or spoon
- Start at 0.5–1ml for any new batch — wait the full onset before any assessment
- Write down your dose and time — impairment affects memory and judgment quickly
- Never share or mix doses — individual tolerance varies; a "standard" dose from someone else may be too much
- Have a sober person present — they can call for help and place you in the recovery position if needed
- Have emergency services number ready — and ensure someone knows what you took
Dangerous Combinations
GHB has a very small number of interactions that are not just dangerous but reliably lethal when doses are misjudged. These are not theoretical risks.
Alcohol
Absolute ContraindicationBoth GHB and alcohol act at GABA receptors as CNS depressants. Their combination produces synergistic (multiplicative) CNS and respiratory depression — not the sum of two doses, but a dramatically amplified effect. Most GHB-related deaths involve alcohol co-ingestion.
Benzodiazepines, Opioids & Other CNS Depressants
High Risk — Respiratory FailureStimulants (MDMA, Cocaine, Amphetamines)
Masking DangerStimulants may partially mask the sedative effects of GHB, making it harder to judge impairment level. This creates a risk of taking a dangerous additional dose without recognizing existing intoxication. Cardiac stress from stimulant + depressant combination is also a concern.
Recognizing & Responding to GHB Overdose
GHB overdose — colloquially "going under" — can occur suddenly, with little warning. There is no antidote. The correct response is supportive care and emergency services.
Signs of GHB Overdose ("Going Under")
Call emergency services immediately if you observe any combination of:
Recovery Position
Do This FirstGHB overdose carries a significant aspiration risk — an unconscious person who vomits can choke. The recovery position is the most important physical intervention.
- Roll the person onto their side (left side preferred)
- Bend the top knee forward to stabilize the position
- Tilt the head back slightly to open the airway
- Clear the mouth of any vomit with your finger if visible
- Monitor breathing continuously until emergency services arrive
- Do not leave the person alone
Calling Emergency Services
Tell Them What Was TakenGood Samaritan laws in most US states protect people who call for help at a drug-related emergency. You will not be prosecuted for calling 911 to report a GHB overdose.
- Call 911 (US) or local emergency number
- Tell them: "I think someone has overdosed on GHB" — this is critical for treatment
- Give your location clearly and stay on the line
- Tell them if alcohol or other drugs were also taken
- There is no antagonist — hospital treatment is supportive (airway management, IV fluids, monitoring)
GHB is metabolized relatively quickly. Most people who receive supportive care recover without permanent injury. Calling early dramatically improves outcomes.
What Not to Do
Common Mistakes- Do not try to walk them off — physical activity doesn't metabolize GHB and can cause injury
- Do not give them coffee or food — if unconscious, aspiration risk is real
- Do not leave them lying on their back — aspiration risk; use recovery position
- Do not give naloxone — GHB is not an opioid; naloxone will not help
- Do not assume they will "sleep it off" safely — without monitoring, aspiration or respiratory depression can be fatal
- Do not give more stimulants to wake them — this increases cardiovascular risk
Dependence & Withdrawal
Regular GHB or GBL use — particularly dosing multiple times per day — causes physical dependence that can develop faster than with alcohol. Withdrawal is medically serious.
GHB Withdrawal Syndrome
Medically Supervised Detox RecommendedGHB acts primarily at GABA-B receptors — the same receptor class involved in alcohol and benzodiazepine dependence. Withdrawal is structurally similar to alcohol or benzo withdrawal and can be severe.
- Mild: Insomnia, anxiety, tremor, sweating, nausea — onset within hours of last dose
- Moderate: Elevated heart rate, hypertension, severe insomnia lasting days
- Severe: Seizures, delirium, psychosis — can be life-threatening
- Rapid onset: Due to GHB's short half-life (30–60 minutes), withdrawal symptoms begin within hours of stopping, even in regular users
Do not stop GHB or GBL abruptly if you use it regularly. Seek medical support. Hospital detox using benzodiazepines (which act on overlapping GABA mechanisms) is the standard approach. SAMHSA helpline: 1-800-662-4357.
Chemsex Context
Specific RisksGHB and GBL are used in chemsex (drug-facilitated sexual activity) contexts, particularly in MSM (men who have sex with men) communities. The harm reduction considerations differ somewhat in this context:
- The MDMA + GHB combination is common and carries particular cardiovascular and overdose risk
- Consent capacity is significantly impaired at recreational GHB doses — this is legally and ethically important in sexual contexts
- Dosing frequency is higher in chemsex settings, increasing dependence risk
- Sharing without accurate measurement is common — and dangerous
- UK resources: GMFA, GHB Harm Reduction UK
Research & Evidence Base
The peer-reviewed science behind GHB/GBL harm reduction recommendations.
GHB Mechanism and Toxicology
GHB is an endogenous neurotransmitter and GABA-B agonist. At recreational doses it produces euphoria, sociability, and sedation through GABA-B receptor agonism in the limbic system and brainstem. Toxicity is primarily respiratory depression mediated through brainstem GABA-B receptors. The compound has a steep dose-response curve that explains its narrow therapeutic window.
Andresen et al. (2011). Gamma-hydroxybutyrate — a drug of abuse. Drug Alcohol Depend. PMC4462042 →Mechanism of GHB Respiratory Toxicity
Animal and clinical studies establish that GHB-induced respiratory depression is primarily mediated through GABA-B receptors in the brainstem. This is the same pathway by which alcohol and benzodiazepines cause respiratory depression — explaining the synergistic (not merely additive) effect when these drugs are combined. The steep dose-response curve means small dose increases can produce large changes in respiratory drive.
Quang & Shannon (2012). GHB respiratory depression. PMID 22561075 →GHB/GBL Use in Rave and Festival Settings
Survey data from festival-attending populations show GHB/GBL is used by 3–8% of rave attendees, with higher rates in chemsex-associated venues. Overdose presentations are disproportionately high relative to use prevalence, largely due to the narrow therapeutic window and frequent combination with alcohol. Most overdose presentations occur at night when alcohol co-use is most common.
Duxbury et al. (2017). GHB/GBL in festival settings — overdose patterns. PMC5610436 →GHB Dependence and Withdrawal Severity
GHB withdrawal can be severe and resembles alcohol or benzodiazepine withdrawal due to shared GABA receptor mechanisms. Case series document seizures, delirium, and psychosis in dependent users attempting abrupt cessation. Medical management with benzodiazepines is the standard of care. Withdrawal severity correlates with dose and frequency of use — regular users (multiple doses per day) are at highest risk.
van Noorden et al. (2010). GHB withdrawal syndrome. PMID 23919445 →GBL vs. GHB: Relative Potency
GBL is a prodrug hydrolyzed to GHB by paraoxonase/lactonase enzymes in the GI tract and blood. Pharmacokinetic studies show GBL has approximately 2–3× the systemic bioavailability of GHB due to more efficient conversion and first-pass pharmacokinetics. Onset is faster (peak plasma at 15–30 min for GBL vs. 30–60 min for GHB), meaning the dose-response is more abrupt and the margin for error is smaller.
Zvosec & Smith (2001). GBL pharmacokinetics relative to GHB. PMID 11386996 →